Skip to main navigation Skip to search Skip to main content

Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous Polyposis

  • Yuji Toiyama
  • , Yasuhiro Inoue
  • , Takahito Kitajima
  • , Masato Okigami
  • , Mikio Kawamura
  • , Aya Kawamoto
  • , Yoshinaga Okugawa
  • , Jyunichiro Hiro
  • , Koji Tanaka
  • , Yasuhiko Mohri
  • , Masato Kusunoki

Research output: Contribution to journal › Article › peer-review

Abstract

A 39-year-old man received a diagnosis of unresectable multiple liver metastases from multiple colorectal cancers with familial adenomatous polyposis. After construction of an ileostomy, modified FOLFOX6 (mFOLFOX6) with panitumumab was administrated because rectal cancer and sigmoid colon cancer are KRAS wild type. The 13 courses of chemotherapy resulted in a marked reduction in the size of liver metastases and sigmoid colon cancer. Consequently, curative resection with total colectomy, ileal pouch anal anastomosis, and liver metastasis resection with radiofrequency ablation was performed. Progression of KRAS wild-type rectal cancer after chemotherapy suggested that each clone from rectal and sigmoid colon cancer might have a different sensitivity to epidermal growth factor receptor antibody. Immunohistochemical analysis revealed loss of PTEN expression in rectal cancer compared with liver metastases from sigmoid colon cancer, showing that the difference of mFOLFOX6 with panitumumab might be related to activation of the PI3K-AKT pathway.

Original languageEnglish
Pages (from-to)795-801
Number of pages7
JournalInternational Surgery
Volume99
Issue number6
DOIs
Publication statusPublished - 01-11-2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Surgery

Fingerprint

Dive into the research topics of 'Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous Polyposis'. Together they form a unique fingerprint.

Cite this